Previous 10 | Next 10 |
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and services to the worldwide life sciences and other key industries, today announced its participation in Benzinga's ALL ACCESS Inve...
Company Invites Individual and Institutional Investors, as well as Analysts and Advisors, to Attend Its Live, Virtual Guest Appearance on Thursday, November 4, 2021 SOUTH EASTON, MA / ACCESSWIRE / November 2, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") , a ...
Pressure BioSciences’ (OTCQB: PBIO ) patented Ultra Shear Technology(TM) ("UST") platform has produced stable, high-quality neem oil nanoemulsions. The nanoemulsions are designed to provide safe, natural, and environmentally friendly pesticides, which can be used to mitigate agricult...
Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail Use SOUTH EASTON, MA / ACCESSWIRE / September 30, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the ...
Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications SOUTH EASTON, MA / ACCESSWIRE / September 29, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the ...
Pressure BioSciences (OTCQB: PBIO ) has announced that it will be presenting at both the Benzinga Healthcare Conference and the Emerging Growth Small Cap Conference. PBIO is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform techn...
Company to Present this Week at the Benzinga Healthcare and Emerging Growth Small Cap Conferences SOUTH EASTON, MA / ACCESSWIRE / September 28, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-bas...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other key industries, today announced continued strong financial ...
Significant Growth Reported in Total Revenue (127%), Instrument Sales (178%), and BaroFold/UST Services (298%); Significant Decrease in Operating Loss (51%) Achieved Investor Call Scheduled for Thursday, August 19, 2021 at 4:30 p.m. EDT SOUTH EASTON, MA / ACCESSWIRE / August 19, 202...
Company to Discuss Strong Q2 2021 Financial Results, Give Update on Current Activities, and Take Questions on Aggressive Growth Plan Laid Out for the Company on August 5, 2021 SOUTH EASTON, MA / ACCESSWIRE / August 18, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Compa...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...